US 10322161
EPHA4 cyclic peptide antagonists for neuroprotection and neural repair
granted A61KA61K38/00A61K38/12
Quick answer
US patent 10322161 (EPHA4 cyclic peptide antagonists for neuroprotection and neural repair) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- Grant date
- Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K38/12, A61P, A61P25/28